NUVL Research and Charts

NUVL - Nuvalent Inc Class A (Healthcare: Biotechnology)

Projected Earnings Date: 2025-11-05 (Delayed quote data 2025-09-16)

Last 78.33	Change ⇓ -1.04 (-1.31%)	Volume 241,578
	Open 79.31	High 80.67	Low 78.04

8EMA (Daily) 79.29	40EMA (Daily) 78.02	50EMA (Daily) 77.89	STO (Daily) 66.678	MACD Hist (Daily) 0.317
8EMA (Weekly) 78.486	40EMA (Weekly) 78.18	50EMA (Weekly) 77.91	STO (Weekly) 48.171	MACD Hist (Weekly) 0.495


Company Profile
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.